These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34404062)

  • 1. [The Treatment of Cancer Cachexia].
    Tanaka S; Takayama K
    Gan To Kagaku Ryoho; 2021 Aug; 48(8):987-991. PubMed ID: 34404062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
    Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anamorelin for cancer cachexia.
    Nishie K; Sato S; Hanaoka M
    Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Graf SA; Garcia JM
    Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Future Prospects of Cancer Cachexia].
    Morita-Tanaka S; Takayama K
    Gan To Kagaku Ryoho; 2022 Jul; 49(7):719-722. PubMed ID: 35851337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome.
    Dev R; Amano K; Naito T; Del Fabbro E
    Curr Oncol Rep; 2024 Jul; 26(7):762-772. PubMed ID: 38771469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.
    Fonseca GWPD; von Haehling S
    Expert Opin Pharmacother; 2021 May; 22(7):889-895. PubMed ID: 33491505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
    Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
    Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
    Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
    Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome.
    Currow DC; Abernethy AP
    Future Oncol; 2014 Apr; 10(5):789-802. PubMed ID: 24472001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
    Currow DC; Maddocks M; Cella D; Muscaritoli M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
    Nakanishi Y; Higuchi J; Honda N; Komura N
    Nihon Yakurigaku Zasshi; 2021; 156(6):370-381. PubMed ID: 34719572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis.
    Taniguchi J; Mikura S; da Silva Lopes K
    Sci Rep; 2023 Sep; 13(1):15257. PubMed ID: 37709824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overview of Cancer-Associated Cachexia].
    Takayama K
    Gan To Kagaku Ryoho; 2019 Dec; 46(12):1814-1817. PubMed ID: 31879394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latest Treatments for Cancer Cachexia: An Overview.
    Watanabe H; Oshima T
    Anticancer Res; 2023 Feb; 43(2):511-521. PubMed ID: 36697073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.